Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?

Lexaria Bioscience Ownership Summary

Lexaria Bioscience is owned by 8.56% institutional investors, 8.15% insiders, and 83.29% retail investors. Armistice capital is the largest institutional shareholder, holding 2.76% of LEXX shares. Invenomic Institutional is the top mutual fund, with 1.13% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexaria Bioscience	8.56%	8.15%	83.29%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	460.00K	2.76%	$966.00K
Invenomic capital management lp	410.73K	2.46%	$862.53K
Geode capital management	166.68K	1.00%	$350.11K
Vanguard group	127.43K	0.76%	$267.61K
Raymond james financial	60.64K	0.36%	$127.34K
Raymond james financial services advisors	48.80K	0.35%	$135.66K
State street	39.30K	0.24%	$82.53K
Blackrock	27.45K	0.20%	$76.30K
Morgan stanley	22.98K	0.17%	$63.89K
Blackrock funding, inc. /de	27.45K	0.16%	$57.63K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Invenomic capital management lp	410.73K	0.04%	$862.53K
Byrne asset management	13.00K	0.02%	$27.30K
Armistice capital	460.00K	0.01%	$966.00K
Oakworth capital	5.00K	0.00%	$10.50K
Raymond james financial services advisors	48.80K	0.00%	$135.66K
Scotia capital	10.00K	0.00%	$21.00K
Wealth enhancement advisory services	13.82K	0.00%	$42.16K
Tower research capital llc (trc)	2.08K	0.00%	$4.37K
Hightower advisors	21.02K	0.00%	$44.15K
Advisor group	2.29K	-	$6.51K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	460.00K	0.01%	460.00K
Raymond james financial	60.64K	-	60.64K
Blackrock	27.45K	-	25.94K
Vanguard group	127.43K	-	18.41K
Geode capital management	166.68K	-	16.29K

Top Sellers

Holder	Shares	% Assets	Change
Invenomic capital management lp	410.73K	0.04%	-65.04K
Gentrust	-	-	-60.00K
Welch group	-	-	-24.00K
Renaissance	-	-	-22.80K
Xtx topco	-	-	-18.63K

New Positions

Holder	Shares	% Assets	Change	Value
Raymond james financial	60.64K	-	60.64K	$127.34K
Scotia capital	10.00K	0.00%	10.00K	$21.00K
Ubs group	116.00	-	116.00	$244.00

Sold Out

Holder	Change
Northwestern mutual wealth management	-9.00
Toronto dominion bank	-13.00
Allworth financial lp	-89.00
Mather group, llc.	-100.00
Aspire private capital	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	25	-7.41%	1,426,411	33.73%	8	14.44%	12	9.09%	2	-50.00%
Sep 30, 2024	26	-7.14%	1,061,074	-48.44%	7	3.47%	10	-28.57%	4	33.33%
Jun 30, 2024	28	12.00%	2,057,835	131.53%	14	21.79%	14	-12.50%	3	-
Mar 31, 2024	25	31.58%	888,794	-25.66%	8	4.73%	16	60.00%	3	-25.00%
Dec 31, 2023	19	35.71%	1,195,589	-32.50%	13	1.84%	10	66.67%	4	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invenomic Institutional	199.02K	1.13%	-1.63K
Vanguard Institutional Extnd Mkt Idx Tr	117.67K	0.67%	56.00
Fidelity Extended Market Index	86.71K	0.49%	-552.00
Fidelity Total Market Index	26.29K	0.15%	-
BlackRock Extended Equity Market K	22.61K	0.14%	-10.00
Extended Equity Market Fund K	22.37K	0.13%	69.00
Fidelity Series Total Market Index	19.80K	0.11%	1.16K
Spartan Extended Market Index Pool F	17.05K	0.10%	552.00
Spartan Extended Market Index Pool E	17.05K	0.10%	552.00
Northern Trust Extended Eq Market Idx	12.25K	0.07%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 02, 2024	CHRISTOPHER RICHARD	Chief Executive Officer	Buy	$51.22K
Dec 03, 2024	CHRISTOPHER RICHARD	Chief Executive Officer	Buy	$67.17K
Aug 12, 2024	TURKEL CATHERINE C.	-	Buy	$5.01K
Jul 31, 2024	Carle Vanessa	Secretary	Sell	$10.27K
Feb 09, 2023	TURKEL CATHERINE C.	-	Buy	$4.27K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	1	1
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

LEXX Ownership FAQ

Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 8.56%, followed by 8.15% insiders and 83.29% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 68.48%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Armistice capital (460K shares, 2.76%), Invenomic capital management lp (410.73K shares, 2.46%), and Geode capital management (166.68K shares, 1.00%). Together, they hold 6.22% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Invenomic capital management lp is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 410.73K Lexaria Bioscience shares, valued at 862.54K$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Invenomic Institutional is the top mutual fund holder of Lexaria Bioscience shares, with 1.13% of its total shares outstanding invested in 199.02K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools